Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (1,074,498)	$ (1,295,911)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,958	3,732
Stock-based compensation expense		3,299
Changes in assets and liabilities:
Prepaid expenses and other current assets	199,102	412,624
Other assets		9,133
Amortization of right-of-use asset	45,654	45,866
Accounts payable	150,347	156,732
Decrease in lease liabilities	(47,529)	(47,109)
Accrued expenses and other current liabilities	24,156	(773,471)
Net cash used in operating activities	(699,810)	(1,485,105)
Cash flows from investing activities:
Purchase of fixed assets		(766)
Net cash used in investing activities		(766)
Cash flows from financing activities
Preferred stock dividend	(68,809)	(206,000)
Net cash used in financing activities	(68,809)	(206,000)
Net decrease in cash and cash equivalents	(768,619)	(1,691,871)
Cash and cash equivalents at beginning of period	1,374,992	6,769,603
Cash and cash equivalents at end of period	606,373	5,077,732
Supplemental disclosure of Cash Flow Information:
Conversion of Series C Preferred Stock to Common Stock	$ 655,154	$ 2,011,351